Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/135504
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSheel, M.-
dc.contributor.authorWood, N.-
dc.contributor.authorMacartney, K.-
dc.contributor.authorButtery, J.-
dc.contributor.authorDinsmore, N.-
dc.contributor.authorMarshall, H.-
dc.contributor.authorElliott, E.-
dc.contributor.authorKynaston, A.-
dc.contributor.authorRichmond, P.-
dc.contributor.authorChateau, D.-
dc.contributor.authorMcIntyre, P.-
dc.date.issued2022-
dc.identifier.citationThe Pediatric Infectious Disease Journal, 2022; 41(6):507-513-
dc.identifier.issn0891-3668-
dc.identifier.issn1532-0987-
dc.identifier.urihttps://hdl.handle.net/2440/135504-
dc.description.abstractBackground: Multiple studies have shown an association between intus susception (IS) and receipt of monovalent or pentavalent rotavirus vaccine (RV) in the previous 21 days. Disease severity is an important consideration for risk-benefit evaluations of RV, but no studies have compared the severity of IS within 21 days of vaccination (vaccine-associated, VA) and later (not temporally-associated, VNA). Methods: We used active hospital-based surveillance in the Australian Pae diatric Active Enhanced Disease Surveillance (PAEDS) network (July 2007 to February 2018) to identify infants ≤9 months of age meeting Brighton level 1 criteria for IS. We used five severity levels: (1) no surgery and length of stay (LOS) ≤1 day, (2) no surgery and LOS ≥2 days, (3) surgery, no bowel resection, (4) bowel resection, and (5) ICU admission. Results: Of 323 eligible cases, 87 (26.9%) were VA and 236 (73.1%) VNA. VA-IS cases (median 21 weeks; 24.1% ≤14 weeks) were significantly younger than VNA-IS cases (median 28 weeks, 7.2% ≤14 weeks). Cases 0–≤14 weeks of age were significantly more likely than cases ≥25 weeks to require bowel resection (relative risk ratio 4.6, 95% CI, 1.48–14.3). This effect was not associated with RV. After adjustment for age and sex, VA-IS was not significantly overrepresented in severity levels 2–5; adjusted RRR of 1.37 (95% CI: 0.61–3.11) for bowel resection in cases 0–≤14 weeks of age. Conclusions: IS was uncommon but significantly more severe under 14 weeks of age. After adjustment for age and sex, IS severity was not related to RV.-
dc.description.statementofresponsibilityMeru Sheel, PhD, Nicholas Wood, PhD, Kristine Macartney, MD, Jim Buttery, PhD, Nicole Dinsmore, BN, Helen Marshall, MD, Elizabeth Elliott, MD, Anne Kynaston, FRACP, Peter Richmond, FRACP, Dan Chateau, PhD, and Peter McIntyre, PhD, on behalf of PAEDS Network.-
dc.language.isoen-
dc.publisherLippincott, Williams & Wilkins-
dc.rightsCopyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.-
dc.source.urihttp://dx.doi.org/10.1097/inf.0000000000003521-
dc.subjectrotavirus vaccine-
dc.subjectintussusception-
dc.subjectpostmarketing surveillance-
dc.subjectRV5-
dc.subjectRV1-
dc.subjectimmunization-
dc.subjectseverity-
dc.subjectmorbidity-
dc.subject.meshHumans-
dc.subject.meshRotavirus-
dc.subject.meshRotavirus Infections-
dc.subject.meshIntussusception-
dc.subject.meshVaccines, Combined-
dc.subject.meshRotavirus Vaccines-
dc.subject.meshVaccination-
dc.subject.meshProspective Studies-
dc.subject.meshChild-
dc.subject.meshInfant-
dc.subject.meshHospitals-
dc.subject.meshAustralia-
dc.titleSeverity of Rotavirus-Vaccine-Associated Intussusception: Prospective Hospital-Based Surveillance, Australia, 2007-2018-
dc.typeJournal article-
dc.identifier.doi10.1097/INF.0000000000003521-
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/GNT1113851-
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/GNT1063629-
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/1155066-
pubs.publication-statusPublished-
dc.identifier.orcidMarshall, H. [0000-0003-2521-5166]-
Appears in Collections:Microbiology and Immunology publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.